Next Generation Rocklatan

NCT06441643 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

426

Enrollment

INDUSTRY

Sponsor class

Conditions

Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: AR-17043 Ophthalmic Solution
DRUG: PG043 Ophthalmic Solution
DRUG: Latanoprost 0.005% Ophthalmic Solution
DRUG: Netarsudil 0.02% Ophthalmic Solution
DRUG: Netarsudil 0.02%/Latanoprost 0.005% Ophthalmic Solution
DRUG: AR-17043 Vehicle

Sponsor

Alcon Research